ArticleNucleic acids research2026
Pds5 regulates sister chromatid cohesion by controlling cohesin ATPase activity through the Eco1-Smc3 acetylation pathway.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cohesin is a highly conserved protein complex essential for sister chromatid cohesion (SCC) and proper chromosome segregation during cell division. Pds5, a critical cohesin subunit, is essential for the function and stability of the cohesin complex on chromatin. However, the precise molecular mechanisms underlying Pds5's essential role remain poorly understood. To elucidate Pds5 function, we employed a genetic bypass suppressor screen to identify genomic mutations that restored viability in the otherwise lethal pds5∆ elg1∆ double mutant strain. Our screen identified three-point mutations in the Smc3 cohesin subunit that rescued the inviability, SCC defects, and reduced Mcd1/Scc1 protein levels associated with Pds5 loss. Remarkably, these smc3 suppressor mutants also rescued the inviability and cohesion defects of the smc3-RR mutant (unable to undergo acetylation by Eco1) and suppressed the temperature sensitivity of an eco1-203 ts allele. Notably, one suppressor mutation, smc3-G1128D, resides within the highly conserved ABC-signature (or C-motif) that is critical for cohesin ATPase activity. Using molecular dynamics simulations and ATPase assays with purified cohesin complexes, we demonstrated that the smc3-G1128D mutant significantly reduces cohesin's ATPase activity. The bypass smc3 mutants suppress the pds5∆ phenotype by bypassing the requirement for Eco1-dependent Smc3 acetylation in cohesion establishment and cell viability. Our findings reveal that PDS5 functions in a pathway that is epistatic to the Eco1-dependent Smc3 acetylation pathway during cohesion establishment, where Pds5 is strictly required to promote Eco1-dependent Smc3 acetylation and inhibit cohesin's ATPase activity. Following cohesion establishment, Pds5 ensures cohesion maintenance by safeguarding cohesin complex integrity. This work reveals new molecular insights into Pds5-mediated cohesin regulation and establishes the critical importance of controlled cohesin ATPase activity for proper SCC maintenance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.